The ReSPect Study - Reducing stigma towards people with issues related to drug use

背景：2020年，英国与毒品有关的死亡人数达到创纪录的4517人。吸毒者面临极端程度的污名化——负面的陈规定型观念导致差别待遇——限制了他们获得保健和药物治疗的机会，而这些可以防止药物相关/全因死亡。污名化与对减少伤害干预措施的支持呈负相关，可能会限制其提供。反污名信息的证据基础有限，同时，污名被用作一种健康促进工具，以阻止药物使用。目的制定信息传递干预措施，减少对药物依赖者的耻辱感，增加对干预措施的支持，以减少与药物相关的伤害。系统地回顾有关信息传递的文献，以减少对pwud的污名。探讨医疗保健、药物治疗、公共卫生和政策利益相关者对PWUD的态度，以及他们对污名化的看法。3 .确定不同类型的信息传递方式对专业人士/公众对PWUD、减少伤害和包容医疗的态度的影响。在与公共卫生伦理学家、决策者和pwud一起举办的研讨会上，探讨将污名工具化的伦理层面。为专业和公众受众制定和传播反污名信息干预措施。

BackgroundThere were a record 4,517 drug-related deaths in the UK in 2020. People who use drugs (PWUD) face extreme levels of stigma - negative stereotyping leading to differential treatment - limiting access to healthcare and drug treatment, which are protective against drug-related/all-cause mortality. Stigma is negatively associated with support for harm reduction (HR) interventions, potentially limiting their provision. The evidence base informing anti-stigma messaging is limited, whilst simultaneously, stigma is exercised as a health promotion tool to deter drug use. AimDevelop messaging interventions to reduce stigma towards people with drug dependence and increase support for interventions to reduce drug-related harm.Objectives1. Systematically review literature on messaging to reduce stigma towards PWUD.2. Explore the attitudes of healthcare, drug treatment, public health, and policy stakeholders towards PWUD and their views on the instrumentalisation of stigma.3. Identify the impact of different types of messaging on professional/public attitudes towards PWUD, harm reduction and inclusion healthcare.4. Interrogate the ethical dimensions of instrumentalising stigma in workshops with public health ethicists, decisionmakers and PWUD.5. Develop and disseminate anti-stigma messaging interventions for professional and public audiences.